We suppose that 1.05 is an optimal cutoff point of Apolipoprotein B for males (sensitivity 58.55%, specificity 57.41%) and 0.98 (sensitivity 64.91%, specificity 58.90%) for females in discriminating individuals with and without pre-CKD eGFR decline. The gene discussed is APOB; the disease is chronic kidney disease.